|
2024
|
Invention
|
Testosterone dodecanoate compositions and methods. Disclosed is a method and oral composition for... |
|
|
Invention
|
Testosterone dodecanoate compositions and methods.
Disclosed is a method and oral composition fo... |
|
|
Invention
|
Oral testosterone therapy. Disclosed are methods and compositions for testosterone replacement th... |
|
|
Invention
|
Oral allopregnanolone compositions and methods of use.
Disclosed is a method and an oral composi... |
|
|
Invention
|
Compositions and methods for treating cns disorders. The present disclosure is drawn to compositi... |
|
|
Invention
|
Oral (17-β)-3-oxoandrost-4-en-17-yl tridecanoate therapy. Disclosed are pharmaceutical compositio... |
|
|
Invention
|
Oral (17-ß)-3-oxoandrost-4-en-17-yl tridecanoate therapy.
Disclosed are pharmaceutical compositi... |
|
2023
|
Invention
|
Bioavailable solid state (17-beta)-hydroxy-4-androsten-3-one esters. Disclosed are bioavailable s... |
|
|
Invention
|
Steroidal compositions.
Provided herein are steroid containing compositions suitable for providi... |
|
|
Invention
|
Method and composition for treating epilepsy.
Disclosed is a method and composition for treating... |
|
|
Invention
|
Method and composition for treating epilepsy. Disclosed is a method and composition for treating ... |
|
|
Invention
|
3α-oh-5β-pregnan-20-one compositions and methods for treating central nervous system disorders. D... |
|
2022
|
Invention
|
Hydroxyprogesterone caproate compositions and methods of use in preventing preterm birth. An HPC ... |
|
|
Invention
|
Oral allopregnanolone compositions and methods of use. Disclosed is a method and an oral composit... |
|
|
Invention
|
Fixed dose oral testosterone undecanoate compositions and use thereof. Disclosed are effective fi... |
|
|
Invention
|
Compositions and methods for treating cns disorders.
The present disclosure is drawn to composit... |
|
|
Invention
|
(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparation and use. Disclo... |
|
|
Invention
|
(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparation and use.
Discl... |
|
|
Invention
|
3alpha-oh-5beta-pregnan-20-one compositions and methods for treating central nervous system disor... |
|
|
Invention
|
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters. Disclosed are bioavailable soli... |
|
2021
|
Invention
|
Liver disease. Methods of treating a liver disease or condition, or a symptom thereof, in a subje... |
|
|
Invention
|
Hydroxyprogesterone caproate compositions and methods of use in preventing preterm birth.
An HPC... |
|
|
Invention
|
Oral (17-ß)-3-oxoandrost-4-en-17-yl tridecanoate therapy. Disclosed are pharmaceutical compositio... |
|
|
Invention
|
Compositions and methods for treating central nervous system disorders. The present disclosure is... |
|
|
Invention
|
Compositions and their use in oral dosing regimens.
Described herein are oral pharmaceutical com... |
|
2020
|
Invention
|
Oral testosterone non-undecanoate therapy. Disclosed are methods and compositions for testosteron... |
|
|
Invention
|
Steroidal compositions. Provided herein are steroid containing compositions suitable for providin... |
|
|
Invention
|
Liver disease.
Methods of treating a liver disease or condition, or a symptom thereof, in a subj... |
|
|
Invention
|
17-hydroxyprogesterone ester-containing oral compositions and related methods. The present invent... |
|
|
Invention
|
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions.
The p... |
|
|
Invention
|
Compositions and methods of treating viral infections.
The present disclosure is drawn to a meth... |
|
|
Invention
|
High-strength testosterone undecanoate compositions. ave range for a male subject is provided. |
|
|
Invention
|
High-strength testosterone undecanoate compositions.
The present disclosure is drawn to pharmace... |
|
|
Invention
|
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs.
Pharmaceut... |
|
2019
|
P/S
|
Pharmaceutical preparations for the treatment of testosterone deficiency |
|
2000
|
P/S
|
Research and development of pharmaceutical preparations and carriers for pharmaceutically active ... |
